DE60001649D1 - Ziprasidonsuspension - Google Patents

Ziprasidonsuspension

Info

Publication number
DE60001649D1
DE60001649D1 DE60001649T DE60001649T DE60001649D1 DE 60001649 D1 DE60001649 D1 DE 60001649D1 DE 60001649 T DE60001649 T DE 60001649T DE 60001649 T DE60001649 T DE 60001649T DE 60001649 D1 DE60001649 D1 DE 60001649D1
Authority
DE
Germany
Prior art keywords
ziprasidonsuspension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60001649T
Other languages
English (en)
Other versions
DE60001649T2 (de
Inventor
Ray Arenson
Hong Qi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22472103&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60001649(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of DE60001649D1 publication Critical patent/DE60001649D1/de
Application granted granted Critical
Publication of DE60001649T2 publication Critical patent/DE60001649T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Cosmetics (AREA)
  • Colloid Chemistry (AREA)
  • General Preparation And Processing Of Foods (AREA)
DE60001649T 1999-05-27 2000-05-08 Ziprasidonsuspension Expired - Lifetime DE60001649T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13626899P 1999-05-27 1999-05-27
PCT/IB2000/000593 WO2000072847A1 (en) 1999-05-27 2000-05-08 Ziprasidone suspension

Publications (2)

Publication Number Publication Date
DE60001649D1 true DE60001649D1 (de) 2003-04-17
DE60001649T2 DE60001649T2 (de) 2003-08-21

Family

ID=22472103

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60001649T Expired - Lifetime DE60001649T2 (de) 1999-05-27 2000-05-08 Ziprasidonsuspension

Country Status (50)

Country Link
EP (1) EP1181018B1 (de)
JP (1) JP3942827B2 (de)
KR (1) KR100477782B1 (de)
CN (1) CN1196486C (de)
AP (1) AP1409A (de)
AR (1) AR022643A1 (de)
AT (1) ATE234097T1 (de)
AU (1) AU777413B2 (de)
BG (1) BG65367B1 (de)
BR (1) BR0010990A (de)
CA (1) CA2371550C (de)
CO (1) CO5170458A1 (de)
CR (1) CR6506A (de)
CU (1) CU23223B7 (de)
CZ (1) CZ20014230A3 (de)
DE (1) DE60001649T2 (de)
DK (1) DK1181018T3 (de)
DZ (1) DZ3049A1 (de)
EA (1) EA003907B1 (de)
EE (1) EE04704B1 (de)
ES (1) ES2191618T3 (de)
GC (1) GC0000190A (de)
GE (1) GEP20033113B (de)
GT (1) GT200000081A (de)
HK (1) HK1046366B (de)
HN (1) HN2000000071A (de)
HR (1) HRP20010878B1 (de)
HU (1) HUP0201297A3 (de)
IL (2) IL145950A0 (de)
IS (1) IS2396B (de)
MA (1) MA26741A1 (de)
MX (1) MXPA01012124A (de)
MY (1) MY127891A (de)
NO (1) NO320296B1 (de)
NZ (1) NZ514764A (de)
OA (1) OA11946A (de)
PA (1) PA8495801A1 (de)
PE (1) PE20010127A1 (de)
PL (1) PL196867B1 (de)
RS (1) RS50089B (de)
SI (1) SI1181018T1 (de)
SK (1) SK284590B6 (de)
SV (1) SV2001000085A (de)
TN (1) TNSN00112A1 (de)
TR (1) TR200103392T2 (de)
TW (1) TWI263498B (de)
UA (1) UA59491C2 (de)
UY (1) UY26166A1 (de)
WO (1) WO2000072847A1 (de)
ZA (1) ZA200109692B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7175855B1 (en) 1999-05-27 2007-02-13 Pfizer Inc. Ziprasidone suspension
CA2389235C (en) 1999-10-29 2007-07-17 Euro-Celtique, S.A. Controlled release hydrocodone formulations
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
EP2283829A1 (de) 2000-10-30 2011-02-16 Euro-Celtique S.A. Hydrocodon-Formulierungen mit gesteuerter Freisetzung
EP1482789A4 (de) * 2002-03-12 2010-12-29 Toyama Chemical Company Ltd Schmackhafte oralsuspension und verfahren
CN1703198A (zh) * 2002-10-25 2005-11-30 辉瑞产品公司 呈混悬剂形式的芳基杂环活性物质的贮库制剂
MXPA05002561A (es) * 2002-10-25 2005-05-05 Pfizer Prod Inc Nuevas formulaciones de liberacion prolongada inyectables.
MXPA03009945A (es) 2002-11-05 2007-04-16 Lg Electronics Inc Montaje para montar una pantalla de toque para un monitor con pantalla de cristal liquido.
US7667037B2 (en) 2003-10-24 2010-02-23 Teva Pharmaceutical Industries Ltd. Processes for preparation of ziprasidone
WO2005107719A2 (en) * 2004-05-06 2005-11-17 Sandoz Ag Pharmaceutical composition comprising hydrophobic drug having improved solubility
WO2005123086A2 (en) * 2004-06-11 2005-12-29 Dr. Reddy's Laboratories Ltd. Ziprasidone dosage form
US20080268034A1 (en) * 2005-01-07 2008-10-30 Girish Karanth Solid Oral Dosage Forms of Ziprasidone Containing Colloidal Silicone Dioxide
SG162811A1 (en) * 2005-06-20 2010-07-29 Elan Pharma Int Ltd Nanoparticulate and controlled release compositions comprising aryl- heterocyclic compounds
WO2007052289A2 (en) 2005-07-22 2007-05-10 Rubicon Research Pvt Ltd. Novel dispersible tablet composition
CN100391458C (zh) * 2006-02-07 2008-06-04 上海医药工业研究院 齐拉西酮或其盐包合物制备方法
KR20080076667A (ko) * 2007-02-15 2008-08-20 주식회사 중외제약 요변성 약학 조성물
JP4336380B1 (ja) * 2008-11-06 2009-09-30 塩野義製薬株式会社 水懸濁性を向上させた細粒剤
JP6272730B2 (ja) * 2014-05-21 2018-01-31 救急薬品工業株式会社 速溶性フィルム剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US5312925A (en) * 1992-09-01 1994-05-17 Pfizer Inc. Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride
US6150366A (en) * 1998-06-15 2000-11-21 Pfizer Inc. Ziprasidone formulations

Also Published As

Publication number Publication date
TWI263498B (en) 2006-10-11
KR100477782B1 (ko) 2005-03-21
WO2000072847A1 (en) 2000-12-07
EA003907B1 (ru) 2003-10-30
NZ514764A (en) 2004-04-30
AU777413B2 (en) 2004-10-14
HUP0201297A2 (en) 2002-08-28
CN1352560A (zh) 2002-06-05
NO320296B1 (no) 2005-11-21
MA26741A1 (fr) 2004-12-20
SK284590B6 (sk) 2005-07-01
MXPA01012124A (es) 2002-06-04
CO5170458A1 (es) 2002-06-27
GC0000190A (en) 2006-03-29
MY127891A (en) 2006-12-29
GEP20033113B (en) 2003-11-25
OA11946A (en) 2006-04-13
CA2371550A1 (en) 2000-12-07
SI1181018T1 (en) 2003-06-30
CZ20014230A3 (cs) 2002-08-14
AR022643A1 (es) 2002-09-04
YU76701A (sh) 2005-07-19
RS50089B (sr) 2009-01-22
UA59491C2 (uk) 2003-09-15
DK1181018T3 (da) 2003-04-22
SV2001000085A (es) 2001-11-08
TNSN00112A1 (fr) 2005-11-10
GT200000081A (es) 2001-11-16
IS6134A (is) 2001-10-30
ES2191618T3 (es) 2003-09-16
JP2003500449A (ja) 2003-01-07
IS2396B (is) 2008-08-15
PL352826A1 (en) 2003-09-08
BG106153A (bg) 2002-06-28
EP1181018B1 (de) 2003-03-12
AU4138500A (en) 2000-12-18
IL145950A (en) 2007-12-03
EE200100633A (et) 2003-02-17
BR0010990A (pt) 2002-03-05
BG65367B1 (bg) 2008-04-30
PL196867B1 (pl) 2008-02-29
CA2371550C (en) 2007-01-02
ZA200109692B (en) 2002-11-26
PA8495801A1 (es) 2001-12-14
NO20015755D0 (no) 2001-11-26
CR6506A (es) 2004-03-24
HN2000000071A (es) 2001-02-02
NO20015755L (no) 2002-01-23
AP2001002346A0 (en) 2001-12-31
EA200101131A1 (ru) 2002-04-25
PE20010127A1 (es) 2001-02-06
DZ3049A1 (fr) 2004-03-27
HRP20010878A2 (en) 2003-06-30
HUP0201297A3 (en) 2005-09-28
IL145950A0 (en) 2002-07-25
AP1409A (en) 2005-06-13
TR200103392T2 (tr) 2002-11-21
HK1046366A1 (en) 2003-01-10
KR20020048307A (ko) 2002-06-22
CU23223B7 (es) 2007-08-30
JP3942827B2 (ja) 2007-07-11
CN1196486C (zh) 2005-04-13
UY26166A1 (es) 2000-12-29
EP1181018A1 (de) 2002-02-27
EE04704B1 (et) 2006-10-16
HK1046366B (zh) 2005-07-29
ATE234097T1 (de) 2003-03-15
HRP20010878B1 (en) 2007-03-31
SK16782001A3 (sk) 2002-09-10
DE60001649T2 (de) 2003-08-21

Similar Documents

Publication Publication Date Title
DE122007000064I2 (de) Erythropoietinkonjugate
DE19983871T1 (de) Fönvorrichtung
DE10084676T1 (de) Einmallanzettvorrichtung
DE50002834D1 (de) Handstempel
DE60013454D1 (de) Wekzeugmaschine
ATE357433T1 (de) 4-pyrimidinyl-n-acyl-l-phenylanine
ATE297895T1 (de) 4-pyridinyl-n-acyl-l-phenylalanine
DE59909346D1 (de) Zylinderkopfdichtung
DE59910286D1 (de) Kniehebel-spannvorrichtung
DE50015451D1 (de) Spülwannensystem
DE60001649D1 (de) Ziprasidonsuspension
DE50009570D1 (de) Wechselcorrugator
DE50008613D1 (de) Sicherungsring
DE50016100D1 (de) Gabtriebs
DE60000107D1 (de) Formschliessvorrichtung
DE50006899D1 (de) Antistatikum
DE10085008T1 (de) Oberflächenbehandlungsdüse
DE50012482D1 (de) Tibiamarknagel
DE50003259D1 (de) Textilie
DE59906520D1 (de) Exzenterzahnradgetriebe
DE19983890T1 (de) Ventiltaktgebungsjustiereinrichtung
DE50008429D1 (de) Kraftstofffraktioniereinrichtung
DE50001640D1 (de) Nahfeldoptische untersuchungsvorrichtung
DE60000485D1 (de) Kulturgefass
DE60002507D1 (de) Bestuckungskopf

Legal Events

Date Code Title Description
8364 No opposition during term of opposition